Tech Company Financing Transactions
AccuraGen Funding Round
Decheng Capital, Junson Capital and StartX participated in a $40 million Series B funding round for AccuraGen. The financing round was announced on 6/3/2016.
Transaction Overview
Company Name
Announced On
6/3/2016
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1505B O'Brien Dr. B
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
We have developed a high-sensitivity, next-generation sequencing-based system for the the detection of cancer mutations in miniscule concentrations of circulating cell-free DNA (cfDNA) in blood.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kang Ying
Chief Information Officer
Johnny Sun
Chief Scientific Officer
Malek Faham
Chief Technical Officer
Shengrong Lin
Co-Founder
Grace Zhao
VP - Bus. Development
Li Weng
VP - Product Management
Paul Tang
Browse more venture capital transactions:
Prev: 6/3/2016: Mediamorph venture capital transaction
Next: 6/3/2016: Droom venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs